Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Metformin Use Linked to Fewer Asthma Attacks - 4 days ago The GLP-1 Agonist Plateau No One's Talking About - about 1 year ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes - 23 days ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings - 23 days ago Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think - 5 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - 27 days ago Remote Interventions From Pharmacists Shown to Improve Blood Glucose Control for Type 2 Diabetes - 2 months ago FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - 4 months ago Teva Launches Generic Formulation of Liraglutide in US - 5 months ago Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia - 8 months ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - 9 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 9 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 11 months ago TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - about 1 year ago
5	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 3 months ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 3 months ago STAT+: Liver disease MASH is next target for obesity drugs in development - 9 months ago STAT+: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds - 11 months ago
7	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Reporter Cell Line Development and Optimization for High Throughput Screening  - 3 months ago
8	Kristen Monaco MedPage Today	Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 4 months ago Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers - 5 months ago Glucose Changes in Type 1 Diabetes May Affect Thinking Speed - 8 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 9 months ago One Class of Antidiabetic Linked With Lower Kidney Stone Risk - 10 months ago Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists - 11 months ago In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective - 11 months ago JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes - 12 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 12 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 12 months ago Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd - about 1 year ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - about 1 year ago FDA Approves Another SGLT2 Inhibitor for Treating CKD - about 1 year ago
9	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 6 months ago
10	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Study Finds Semaglutide Improves Chronic Kidney Disease in Patients With Type 2 Diabetes - 6 months ago

Journalists covering glucokinase